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The onset of diabetes relative to clinical diagnosis was estimated in Egyptians with non- 
insulindependent diabetes mellitus (NIDDM) based on the relationship between retinopathy 
and duration of diabetes. Between July 1992 and October 1993 the Diabetes in Egypt 
(DIE) Project performed a cross-sectional, population-based survey with clinical and 
laboratory follow-up to describe the prevalence of microvascular, neuropathic, and 
macrovascular complications among Egyptians a 20 years of age with diagnosed diabetes, 
previously undiagnosed diabetes, impaired glucose tolerance, and normal glucose tolerance. 
The sample of persons with diabetes diagnosed prior to the survey had medical examinations 
which included a dilated eye examination and retinal photographs. Generalized linear 
models were used to relate the probability of retinopathy to duration of diabetes. Among 
218 persons with diabetes diagnosed prior to the DIE project, 87 (40 %) had diabetic 
retinopathy. The onset of retinopathy was estimated to occur 2.6 years (p = 0.04) prior 
to clinical diagnosis. The estimated annual incidence of retinopathy was 5 % and the 
estimated prevalence at the time of clinical diagnosis of diabetes was 12 %. On the basis 
of reports that retinopathy does not occur until approximately 5 years after the development 
of diabetes, the onset of NlDDM was estimated to occur 7.6 years prior to i ts clinical 
diagnosis. This estimate of the onset of NIDDM in Egyptians is comparable to other 
estimates reported for US and Australian populations. 
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Introduction 
Undiagnosed diabetes is an important clinical and public 
health problem. World-wide, half of all cases of diabetes 
are undiagnosed.' The onset of non-insulindependent 
(Type 2) diabetes mellitus (NIDDM) is suspected to 
precede its clinical diagnosis by several years because 
diabetic microvascular complications that take years to 
develop are often present at the time of clinical diagnosis. 
At clinical diagnosis, as many as 29 'YO of persons with 
diabetes have retinopathy,* 8 % have nephr~pathy,~ and 
9 'YO have neuropathy.* 
Because the microvascular structures in the eye can 
be directly examined, retinopathy is usually the first 
of the diabetic microvascular complications detected. 
Retinopathy is a sensitive and specific indicator that can 
be used to estimate the duration of NIDDM and 
retrospectively determine its onset. Nephropathy and 
neuropathy are generally defined using arbitrary thresh- 
olds, and are less sensitive than retinal abnormalities as 
markers of diabetic microvascular complications. 
This study was designed to examine the relationships 
among clinical diagnosis, duration of diabetes, and 
presence of retinopathy. The findings can be used to 
estimate the actual onset of NIDDM. 
Better understanding of the natural history of diabetes 
may facilitate the development of diabetes control 
strategies. A recent studyZ estimated that the onset of 
retinopathy occurs 4-7 years before clinical diagnosis of 
NIDDM. Near-normal blood glucose control has recently 
been shown to delay development and slow progression 
of the microvascular and neurologic complications of 
IDDM.5*6 It is possible that improved glycaemic control 
and aggressive cardiovascular risk reduction during the 
preclinical phase of NIDDM may be more beneficial 
than later treatment. 
Patients and Methods 
The method of identification and description of the study 
Population has been reported elsewhere.' Between July 
1992 and October 1993, the Diabetes in Egypt (DIE) 
Project performed a cross-sectional, population-based 
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survey with clinical and laboratory follow-up to describe 
the prevalence of microvascular, neuropathic, and macro- 
vascular complications among Egyptians 2 2 0  years of 
age. Informed consent was obtained from all participants 
before field workers collected information about diabetes 
and its duration. Duration of diabetes was defined as 
time since participants were first told by a physician 
they had diabetes. All respondents at high risk for 
diabetes (random capillary glucose 25.6 mmol 1 - l )  and 
a random sample of those at low risk for undiagnosed 
diabetes (random capillary glucose < 5.6 mmol I-') were 
invited to have a more extensive medical examination 
done at the Diabetes Institute. 
During the DIE Project survey 395 persons with 
diabetes diagnosed by a physician prior to the DIE 
project had medical examinations which included an 
oral glucose tolerance test to confirm diabetes using 
World Health Organization criteria,8 a dilated eye 
examination by an ophthalmologist, and fundus photo- 
graphs taken through the dilated pupil of each eye 
with a Canon retinal camera (CR4-45NM, Canon Inc., 
Tokyo, Japan). 
The fundus photographs were graded by the University 
of Wisconsin Fundus Photo Reading Centre using a 
modification of the Airlie House classification scheme 
for diabetic retin~pathy.~ Retinopathy was considered 
present when there were retinal microaneurysms either 
alone or with other nonproliferative changes, when there 
were preproliferative or proliferative changes, or when 
vitreous haemorrhage had occurred. 
Of the 395 persons with diabetes diagnosed by a 
physician prior to the DIE Project, 289 had gradable 
retinal photographs. Those who did not have gradable 
photographs were similar to those who had gradable 
retinal photographs. Average age was 53 vs 56 years. 
Average duration of diabetes was 1 1  vs 10 years. Insulin 
use was 19 vs 21 o/o and the proportion of females was 
63 vs 69 YO. The 10 persons were diagnosed at <30 
years of age and who used insulin were excluded 
because they were considered to have IDDM. Fourteen 
persons had missing data on clinical diagnosis. Addition- 
ally, persons with the time since clinical diagnosis >20 
years ( n  = 47) were excluded because of concerns related 
to selective mortality. This resulted in a study population 
of 218 persons. 
Logistic regression was used in a preliminary analysis 
to test if the probability of retinopathy was related to 
diabetes duration, sex, age, and urban versus rural 
residence. For the primary analyses we used generalized 
linear models.'O These are a class of statistical models 
that includes classical linear models (i.e. least squares 
regression), log-linear models, probit and logit (i.e. 
logistic regression) models, and several models for 
survival data. Specification of a model within this class 
requires a link function and a probability distribution. 
For example, a log link and Poisson distribution is  
equivalent to a log-linear model. An identity link 
and normal distribution is equivalent to least squares 
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regression. A logit link and binomial distribution is 
equivalent to logistic regression. In this study a comp- 
lementary log-log link and binomial probability distri- 
bution is used. The response variable was the presence 
of retinopathy. The predictor variable was the logarithm 
of the quantity: number of years diabetes was present 
after clinical diagnosis plus the duration of diabetes prior 
to clinical diagnosis. This model has the form 
In( - In(1 - F(0))  = p + a In(t+ 61, 
where f ( g  is the probability of retinopathy within time 
t, and t is duration of diabetes since clinical diagnosis. 
The duration of diabetes prior to clinical diagnosis, b, 
was estimated using the profile likelihood.1° The profile 
likelihood method involves fitting the model for a series 
of fixed values of ti, and then choosing the model that 
provides the best fit to the data as measured by the 
maximized likelihood function. The above model implies 
that the distribution of time to retinopathy is  Weibu1l.l' 
The Weibull is a flexible survival distribution that includes 
increasing, decreasing, and constant hazard functions. 
The confidence interval (CI) for duration of diabetes 
prior to clinical diagnosis was also estimated from 
the profile likelihood. Confidence intervals for other 
parameters will be slightly underestimated because b is 
treated as known in the computations. This was corrected 
by using bootstrap methods.IZ Bootstrap percentile confi- 
dence intervals were calculated based on 2000 repli- 
cations. Confidence intervals of any desired level can 
be obtained using bootstrap methods. 
All the parameters in our final model are known to 
be greater than zero. Therefore it is  natural to think in 
terms of one-sided pvalues and one-sided confidence 
intervals. However, as a compromise between presenting 
95 Yo one-sided confidence intervals and the more 
familiar 95 Yo two-sided confidence intervals, 90 Yo two- 
sided confidence intervals are presented. Models were 
fit using the CLIM statistical package" and additional 
calculations were programmed in GAUSS." 
Results 
There were 21 8 persons with clinically diagnosed NIDDM 
in the study population. The median age was 54 (range 
22-72) years, 33 Yo were male, 89 YO resided in urban 
areas, and 13 Yo used insulin. The duration since clinical 
diagnosis was 1-5 years for 38 YO, 6-1 0 years for 36 %, 
and 11-20 years for 26%. Diabetic retinopathy was 
present in 40 %. Duration-specific retinopathy rates were 
20 YO for 1-5 years, 51 % for 6-1 0 years, and 54 % for 
11-20 years. 
Based on logistic regression analyses, the probability 
of retinopathy significantly increased with the duration 
since clinical diagnosis ( p  < 0.001 1. Results are presented 
in Table 1. After adjustment for duration since clinical 
diagnosis, retinopathy was not related to age (p=O.6), 
sex ( p =  0.8), or urban versus rural residence (p = 0.6). 
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Table 1. Results of fitting a logistic regression model to the retinopathy data (n = 21 8) 
Variable Parameter Standard pvalue Odds ratio 95 Yo CI 
estimate error 
~ ~~ 
Intercept -0.88 1 .oo 
Duration (yr) 0.1 2 0.03 <0.001 1.12 (1.06, 1.19) 
Age (yr) -0.01 0.02 0.6 0.99 (0.95, 1.03) 
Female vs male 0.09 0.31 0.8 1.09 (0.60, 2.00) 
Rural vs urban -0.26 0.50 0.6 0.77 (0.29, 2.06) 
Our final generalized linear model, plotted in Figure 
1, simplified to 
F(t) = 1 - exp[-0.050(t+ 2.611 
The onset of retinopathy was estimated to occur 2.6 
years (90 'YO CI 0.3-8.4 years) prior to clinical diagnosis. 
Testing the hypothesis that the onset of retinopathy began 
at clinical diagnosis yielded a pvalue of 0.04. The 
estimated annual incidence of retinopathy was 5.0 YO 
(90 % CI 3.0-7.0 'YO). The prevalence of retinopathy at 
diagnosis of diabetes was estimated to be 12 'YO (90% CI 
To check the appropriateness of the model, the data 
were divided into five groups of approximately 40 
persons by increasing duration since clinical diagnosis 
of NIDDM. Prevalence estimates by group versus duration 
since clinical diagnosis for each observation are included 
in Figure 1. This shows a reasonable fit to the data. 
Note the model fitting process used the individual, 
ungrouped data. 
1-24 %). 
* 
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Figure 1. Probability of diabetic retinopathy versus time since 
diagnosis of diabetes (n = 21 8). The solid line is the model 
based prediction. The points represent a grouping of the data 
into five approximately equal size groups 
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Discussion 
Using the relationship between retinopathy and the time 
since clinical diagnosis, we estimated that no retinopathy 
was present in the population 2.6 years prior to the 
clinical diagnosis of their diabetes. Assuming that diabetic 
retinopathy does not occur until approximately 5 years 
after development of diabetes,14 we estimated that the 
onset of diabetes occurs approximately 7.6 years prior 
to clinical diagnosis. Using these assumptions our esti- 
mate of the onset of NIDDM prior to diagnosis is lower 
than recent reports in US and Australian populations.* 
However, the confidence interval (0.3-8.4 years) for 
our estimate includes the values reported for US and 
Australian populations. 
We estimated in this population that at the time of 
clinical diagnosis the prevalence of diabetic retinopathy 
was 12 YO. This estimate of the prevalence of retinopathy 
is higher than reported in a rural Australian population 
and lower than that in USz and European  population^.'^*'^ 
Factors that might explain the estimated differences 
among populations include behaviours related to seeking 
care, access to medical care, physician practices in 
pursuing the diagnosis of diabetes, the severity of 
hyperglycaemia, the prevalence of comorbidities which 
accelerate complications, and variations in racial and 
ethnic susceptibility to complications. However, the 
prevalence of retinopathy in populations where studies 
include persons detected through active case finding, 
such as population-based surveys, or intense screening 
activity, will tend to be lower because diabetes is more 
likely to be detected at an earlier stage, that is, before 
the clinical diagnosis is made. Caution must be taken in 
comparing various studies. In the Egyptian population, 
the prevalence of retinopathy in persons with diabetes 
first detected through population-based screening and 
diagnostic testing during the Diabetes in Egypt survey 
was 15 Yo. 
We also estimate a 47 % 10 year incidence rate of 
retinopathy (5  YO annual incidence). The WESDR" found 
a 10-year incidence rate of 79 Yo in insulin-taking persons 
30 years or older and 67% in non-insulin-taking 
persons 30 years or older with diabetes. The severity of 
hyperglycaemia, other comorbidities, and racial ethnic 
differences may also explain these differences. 
The approach we used to predict the onset of NlDDM 
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has several practical advantages when compared to other 
methods.* First, the predicted prevalence of retinopathy 
is constrained to lie between 0 and 100 O/O. Second, the 
data do not need to be grouped to fit the model, which 
is  important because the data set analysed here is not 
large. Third, the duration of diabetes prior to clinical 
diagnosis is a parameter in the model and is estimated 
as part of the model fitting process. Furthermore, we 
excluded persons with duration since clinical diagnosis 
>20 years because there may be higher mortality within 
this group in persons with more advanced microvascular 
disease thus introducing bias. Including these persons 
could lead to an underestimate of annual incidence and 
an overestimate of duration prior to  diagnosis. 
Persons with diabetes may benefit from improved 
glycaemic control and aggressive cardiovascular risk 
reduction. Thus, more aggressive measures to  detect 
diabetes in earlier stages and initiate comprehensive 
diabetes management may be warranted. Because risk 
factors for diabetes, including obesity and sedentary life 
style are common in Egypt' and increasing elsewhere," 
the prevalence of diabetes is  expected to increase. The 
burden of suffering caused by diabetes is  large and may 
increase if interventions are not undertaken. 
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